Deirdre Thompson
Investor Relations, ICR
Replay available
ICU Medical, Inc. (NASDAQ: ICUI) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.

Investor Relations, ICR
Chief Executive Officer & Chairman
Chief Financial Officer
Analyst, Raymond James
Analyst, KeyBank Capital Markets
Analyst, Needham
Analyst, CJS Securities
Analyst, Piper Sandler
Unknown
Good afternoon, everyone, and welcome to ICU Medical's third quarter 2025 earnings conference call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note that today's event is being recorded. I would now like to turn the conference over to Deirdre Thompson of ICR. Please go ahead. Good afternoon, everyone. Thank you for joining us to discuss ICU Medical's financial results for the third quarter of 2025. On the call today representing ICU Medical is Vivek Jain, Chief Executive Officer and Chairman, and Brian Bunnell, Chief Financial Officer. We wanted to let everyone know that we have a presentation accompanying today's prepared remarks. To view the presentation, please go to our investor page and click on events calendar, and it will be under the third quarter 2025 event. Before we start our prepared remarks, I want to touch upon any forward-looking statements made during the call. including beliefs and expectations about the company's future results. Please be aware they are based on the best available information to management and assumptions that are reasonable. Such statements are not intended to be a representation of future results and are subject to risk and uncertainties. Future results may differ materially from management's current expectations. We refer all of you to the company's SEC filings for more detailed information on the risk and uncertainties that have a direct bearing on operating results and financial position. Please note that during today's call, we will also discuss non-GAAP financial measures, including results on an adjusted basis. We believe these financial measures can facilitate a more complete analysis and greater transparency into ICU Medical's ongoing res...